Proposed Extension of Existing Collection; Comment Request, 59842-59843 [2019-24078]
Download as PDF
59842
Federal Register / Vol. 84, No. 215 / Wednesday, November 6, 2019 / Notices
Vermont
Virginia
Virgin Islands
Washington
West Virginia
Wisconsin
Wyoming
This certification is for the maximum
additional credit allowable under
Section 3302(b) of the Code, subject to
the limitations of Section 3302(c) of the
Code.
Signed at Washington, D.C., on
October 31, 2019.
lllllllllllllllllll
EUGENE SCALIA
[FR Doc. 2019–24216 Filed 11–5–19; 8:45 am]
BILLING CODE 4510–FW–P
DEPARTMENT OF LABOR
Office of Workers’ Compensation
Programs
Proposed Extension of Existing
Collection; Comment Request
Divison of Federal Employees’
Compensation, Office of Workers’
Compensation Programs, Labor.
ACTION: Notice.
AGENCY:
The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995. This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed.
DATES: Written comments must be
submitted to the office listed in the
addresses section below on or before
January 6, 2020.
ADDRESSES: You may submit comments
by mail, delivery service, or by hand to
Anjanette Suggs, U.S. Department of
Labor, 200 Constitution Ave. NW, Room
S–3323, Washington, DC 20210; by fax,
(202) 354–9660, or email to
suggs.anjanette@dol.gov. Please use
only one method of transmission for
comments (mail or email).
SUPPLEMENTARY INFORMATION:
I. Background: The purpose of the
Paperwork Reduction Act of 1995
(PRA), 44 U.S.C. 3501 et seq., include
SUMMARY:
VerDate Sep<11>2014
17:43 Nov 05, 2019
Jkt 250001
enhancing the quality and utility of
information the Federal government
requires and minimizing the paperwork
and reporting burden of affected
entitities. The public is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number (44 U.S.C. 3507). Also,
notwithstanding any other provisions of
law, no person shall be subject to
penalty for failing to comply with a
collection of information if there is not
a current valid OMB control number (44
U.S.C. 3512).
The DOL is requesting an approval of
an extension of this information
collection. This information collection
is essential to the mission of DOL and
the Office of Workers’ Compensation
Programs (OWCP), to monitor and
assure the appropriate use of opioids
and compounded drugs in treating
employment-related injuries under the
Federal Employees Compensation Act
(FECA), 5 U.S.C. 8101 et seq.
The FECA statute grants OWCP
discretion to provide an injured
employee the ‘‘services, appliances, and
supplies prescribed or recommended by
a qualified physician’’ which OWCP
considers ‘‘likely to cure, give relief,
reduce the degree or the period of
disability, or aid in lessening the
amount of the monthly compensation.’’
5 U.S.C. 8103. In other words, OWCP is
mandated to provide medical supplies
and services—including prescription
drugs such as opioids and compounded
drugs—that it considers medically
necessary. 20 CFR 10.310. The FECA
statute and implementing regulations
are not primarily focused on managing
doctor/patient decisions relating to
medication therapy and, with the
exception of few limitations on fentanyl
(an opioid) and other controlled
substances, the FECA program policy on
pharmacy benefits has generally been a
policy of payment for prescribed
medications in accordance with a fee
schedule based on a percentage of the
average wholesale price (AWP) for drugs
identified by a National Drug Code
(NDC). See 20 CFR 10.809. To this end,
the FECA program has a prior
authorization policy (based on medical
necessity) for opioid and compounded
drugs utilizing the pre-authorization
authority already contained in its
regulations at 20 CFR 10.310(a) and
§ 10.800(b).
Information collected on the CA–26
and the CA–27, require an injured
worker’s treating physician to answer a
number of questions about the
prescribed opioids and/or compounded
drugs and certify that they are medically
necessary to treat the work-related
injury. The responses to the questions
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
on the forms are intended to ensure that
treating physicians have considered
non-opioid and non-compounded drug
alternatives, and are only prescribing
the most cost effective and medically
necessary drugs. The forms also permit
OWCP to more easily track the volume,
type, and characteristics of opioids and
compounded drugs authorized by the
FECA program. The forms serve as a
means for injured workers to continue
receiving opioids and compounded
drugs only where medically necessary
and simultaneously give OWCP greater
oversight in monitoring their
appropriate use and gather additional
data about their use.
II. Review Focus: The DOL is
particularly interested in comments
which:
* Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
* evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
* enhance the quality, utility and
clarity of the information to be
collected; and
* minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
III. Current Actions: The DOL seeks
the approval for the extension of this
currently approved information
collection in order to carry out its
responsibility to meet the statutory
requirements of the Federal Employees’
Compensation Act.
Agency: Office of Workers’
Compensation Programs.
Type of Review: Extension.
Title: Authorization and Certification/
Letter of Medical Necessity.
OMB Number: 1240–0055.
Agency Number: CA–26 and CA–27.
Affected Public: Individuals or
households; Businesses or other forprofit.
Total Respondents: 45,600.
Total Annual Responses: 45,600.
Estimated Total Burden Hours:
22,800.
Estimated Time per Response: 30
minutes.
Frequency: On occasion.
Total Burden Cost (capital/startup):
$0.
E:\FR\FM\06NON1.SGM
06NON1
Federal Register / Vol. 84, No. 215 / Wednesday, November 6, 2019 / Notices
Total Burden Cost (operating/
maintenance): $0.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget approval of the
information collection request; they will
also become a matter of public record.
Ajanette Suggs,
Agency Clearance Officer, Office of Workers’
Compensation Programs, US Department of
Labor.
[FR Doc. 2019–24078 Filed 11–5–19; 8:45 am]
BILLING CODE 4510–CH–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: (19–078)]
National Space-Based Positioning,
Navigation, and Timing Advisory
Board; Meeting
National Aeronautics and
Space Administration (NASA).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, as
amended, and the President’s 2004 U.S.
Space-Based Positioning, Navigation,
and Timing (PNT) Policy, the National
Aeronautics and Space Administration
(NASA) announces a meeting of the
National Space-Based Positioning,
Navigation, and Timing (PNT) Advisory
Board.
DATES: Wednesday, November 20, 2019,
8:30 a.m. to 5:30 p.m.; and Thursday,
November 21, 2019, 8:30 a.m. to 1:00
p.m., Local Time.
ADDRESSES: Hilton Cocoa Beach
Oceanfront, Grand Ballroom, 1550
North Atlantic Ave. Cocoa Beach,
Florida, 32931.
FOR FURTHER INFORMATION CONTACT: Mr.
James J. Miller, Designated Federal
Official, Human Exploration and
Operations Mission Directorate, NASA
Headquarters, Washington, DC 20546,
(202) 358–4417, fax (202) 358–4297, or
jj.miller@nasa.gov.
SUPPLEMENTARY INFORMATION: The
meeting will be open to the public up
to the seating capacity of the room. It is
imperative that the meeting be held on
these dates to accommodate the
scheduling priorities of the key
participants. Visitors will be requested
to sign a visitor’s register.
The agenda for the meeting includes
the following topics:
• Update on U.S. Space-Based
Positioning, Navigation and Timing
(PNT) Policy and Global Positioning
System (GPS) modernization.
SUMMARY:
VerDate Sep<11>2014
17:43 Nov 05, 2019
Jkt 250001
59843
• Prioritize current and planned GPS
capabilities and services while assessing
future PNT architecture alternatives
with a focus on affordability.
• Examine methods in which to
Protect, Toughen, and Augment (PTA)
access to GPS/Global Navigation
Satellite Systems (GNSS) services in key
domains for multiple user sectors.
• Assess economic impacts of GPS/
GNSS on the United States and in select
international regions, with a
consideration towards effects of
potential PNT service disruptions if
radio spectrum interference is
introduced.
• Review the potential benefits,
perceived vulnerabilities, and any
proposed regulatory constraints to
accessing foreign Radio Navigation
Satellite Service (RNSS) signals in the
United States and subsequent impacts
on multi-GNSS receiver markets.
• Explore opportunities for enhancing
the interoperability of GPS with other
emerging international GNSS.
• Examine emerging trends and
requirements for PNT services in U.S.
and international fora through PNT
Board technical assessments, including
back-up services for terrestrial,
maritime, aviation, and space users.
initial appraisal of a senior executive’s
performance by the supervisor and
considers recommendations to the
appointing authority regarding the
performance of the senior executive.
The following have been designated
as members of the 2019 Performance
Review Board of the National
Transportation Safety Board (NTSB):
Mr. Edward Benthall, Chief Financial
Officer, National Transportation Safety
Board, PRB Chair.
Ms. Barbara A. Czech, Deputy
Director, Office of Research and
Engineering, National Transportation
Safety Board.
Mr. Jerold Gidner, Principal Deputy
Special Trustee, Office of the Special
Trustee for American Indians,
Department of Interior.
Ms. Claudia J. Postell, Associate
Commissioner, Office of Civil Rights
and Equal Opportunity, Social Security
Administration.
Mr. Paul S. Sledzik, Deputy Managing
Director, National Transportation Safety
Board.
Ms. Katherine Herrera, Deputy
Technical Director, Defense Nuclear
Facilities Safety Board (alternate).
Ms. Susan A. Kantrowitz, Director,
Office of Administration, National
Transportation Safety Board (alternate).
Carol J. Hamilton,
Advisory Committee Management Officer
(Acting), National Aeronautics and Space
Administration.
Dated: November 1, 2019.
LaSean R. McCray,
Alternate Federal Register Liaison.
[FR Doc. 2019–24201 Filed 11–5–19; 8:45 am]
[FR Doc. 2019–24217 Filed 11–5–19; 8:45 am]
BILLING CODE 7533–01–P
BILLING CODE 7510–13–P
NATIONAL TRANSPORTATION
SAFETY BOARD
SES Performance Review Board
AGENCY:
National Transportation Safety
Board.
ACTION:
Notice.
Notice is hereby given of the
appointment of members of the National
Transportation Safety Board,
Performance Review Board (PRB).
FOR FURTHER INFORMATION CONTACT:
Emily T. Carroll, Chief, Human
Resources Division, Office of
Administration, National Transportation
Safety Board, 490 L’Enfant Plaza SW,
Washington, DC 20594–0001, (202) 314–
6233.
SUPPLEMENTARY INFORMATION: Section
4314(c)(1) through (5) of Title 5, United
States Code requires each agency to
establish, in accordance with
regulations prescribed by the Office of
Personnel Management, one or more
SES Performance Review Boards (PRB).
The board reviews and evaluates the
SUMMARY:
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
NUCLEAR REGULATORY
COMMISSION
[Docket No. 11006367; NRC–2019–0213]
Perma-Fix Northwest Richland, Inc.
Nuclear Regulatory
Commission.
ACTION: Export license application;
opportunity to comment, request a
hearing, and petition for leave to
intervene.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is considering
issuing an export license (XW025),
requested by Perma-Fix Northwest
Richland, Inc. (PFNW). On September
27, 2019, PFNW filed an application
with the NRC for a license to export
radioactive waste. The request seeks
NRC approval for the export of low-level
radioactive waste to Italy. The NRC is
providing notice of the opportunity to
request a hearing on PFNW’s revised
application. The request seeks the
NRC’s approval of the application
authorizing the export of radioactive
waste to Italy.
SUMMARY:
E:\FR\FM\06NON1.SGM
06NON1
Agencies
[Federal Register Volume 84, Number 215 (Wednesday, November 6, 2019)]
[Notices]
[Pages 59842-59843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24078]
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Office of Workers' Compensation Programs
Proposed Extension of Existing Collection; Comment Request
AGENCY: Divison of Federal Employees' Compensation, Office of Workers'
Compensation Programs, Labor.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Labor, as part of its continuing effort to
reduce paperwork and respondent burden, conducts a preclearance
consultation program to provide the general public and Federal agencies
with an opportunity to comment on proposed and/or continuing
collections of information in accordance with the Paperwork Reduction
Act of 1995. This program helps to ensure that requested data can be
provided in the desired format, reporting burden (time and financial
resources) is minimized, collection instruments are clearly understood,
and the impact of collection requirements on respondents can be
properly assessed.
DATES: Written comments must be submitted to the office listed in the
addresses section below on or before January 6, 2020.
ADDRESSES: You may submit comments by mail, delivery service, or by
hand to Anjanette Suggs, U.S. Department of Labor, 200 Constitution
Ave. NW, Room S-3323, Washington, DC 20210; by fax, (202) 354-9660, or
email to [email protected]. Please use only one method of
transmission for comments (mail or email).
SUPPLEMENTARY INFORMATION:
I. Background: The purpose of the Paperwork Reduction Act of 1995
(PRA), 44 U.S.C. 3501 et seq., include enhancing the quality and
utility of information the Federal government requires and minimizing
the paperwork and reporting burden of affected entitities. The public
is not required to respond to a collection of information unless it
displays a currently valid OMB control number (44 U.S.C. 3507). Also,
notwithstanding any other provisions of law, no person shall be subject
to penalty for failing to comply with a collection of information if
there is not a current valid OMB control number (44 U.S.C. 3512).
The DOL is requesting an approval of an extension of this
information collection. This information collection is essential to the
mission of DOL and the Office of Workers' Compensation Programs (OWCP),
to monitor and assure the appropriate use of opioids and compounded
drugs in treating employment-related injuries under the Federal
Employees Compensation Act (FECA), 5 U.S.C. 8101 et seq.
The FECA statute grants OWCP discretion to provide an injured
employee the ``services, appliances, and supplies prescribed or
recommended by a qualified physician'' which OWCP considers ``likely to
cure, give relief, reduce the degree or the period of disability, or
aid in lessening the amount of the monthly compensation.'' 5 U.S.C.
8103. In other words, OWCP is mandated to provide medical supplies and
services--including prescription drugs such as opioids and compounded
drugs--that it considers medically necessary. 20 CFR 10.310. The FECA
statute and implementing regulations are not primarily focused on
managing doctor/patient decisions relating to medication therapy and,
with the exception of few limitations on fentanyl (an opioid) and other
controlled substances, the FECA program policy on pharmacy benefits has
generally been a policy of payment for prescribed medications in
accordance with a fee schedule based on a percentage of the average
wholesale price (AWP) for drugs identified by a National Drug Code
(NDC). See 20 CFR 10.809. To this end, the FECA program has a prior
authorization policy (based on medical necessity) for opioid and
compounded drugs utilizing the pre-authorization authority already
contained in its regulations at 20 CFR 10.310(a) and Sec. 10.800(b).
Information collected on the CA-26 and the CA-27, require an
injured worker's treating physician to answer a number of questions
about the prescribed opioids and/or compounded drugs and certify that
they are medically necessary to treat the work-related injury. The
responses to the questions on the forms are intended to ensure that
treating physicians have considered non-opioid and non-compounded drug
alternatives, and are only prescribing the most cost effective and
medically necessary drugs. The forms also permit OWCP to more easily
track the volume, type, and characteristics of opioids and compounded
drugs authorized by the FECA program. The forms serve as a means for
injured workers to continue receiving opioids and compounded drugs only
where medically necessary and simultaneously give OWCP greater
oversight in monitoring their appropriate use and gather additional
data about their use.
II. Review Focus: The DOL is particularly interested in comments
which:
* Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
* evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
* enhance the quality, utility and clarity of the information to be
collected; and
* minimize the burden of the collection of information on those who
are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
III. Current Actions: The DOL seeks the approval for the extension
of this currently approved information collection in order to carry out
its responsibility to meet the statutory requirements of the Federal
Employees' Compensation Act.
Agency: Office of Workers' Compensation Programs.
Type of Review: Extension.
Title: Authorization and Certification/Letter of Medical Necessity.
OMB Number: 1240-0055.
Agency Number: CA-26 and CA-27.
Affected Public: Individuals or households; Businesses or other
for-profit.
Total Respondents: 45,600.
Total Annual Responses: 45,600.
Estimated Total Burden Hours: 22,800.
Estimated Time per Response: 30 minutes.
Frequency: On occasion.
Total Burden Cost (capital/startup): $0.
[[Page 59843]]
Total Burden Cost (operating/maintenance): $0.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
approval of the information collection request; they will also become a
matter of public record.
Ajanette Suggs,
Agency Clearance Officer, Office of Workers' Compensation Programs, US
Department of Labor.
[FR Doc. 2019-24078 Filed 11-5-19; 8:45 am]
BILLING CODE 4510-CH-P